UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings (Accumulated Deficit)	Retained Earnings (Accumulated Deficit) Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive (Loss)
Balance, beginning of period (in shares) at Dec. 31, 2020			80,890
Balance, beginning of period at Dec. 31, 2020	$ 542,172	$ (52,205)	$ 809	$ 204,432	$ (61,604)	$ 339,879	$ 9,399	$ (2,948)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)			(70)
Repurchase of common stock	(9,146)		$ (1)	(9,145)
Issuance of common stock for share-based compensation plans (in shares)			402
Issuance of common stock for stock compensation plans	(25,509)		$ 4	(25,513)
Issuance of common stock under the employee stock purchase plan (in shares)			24
Issuance of common stock under the employee stock purchase plan	2,288			2,288
Stock-based compensation	30,100			30,100
Cash dividends declared ($0.03 per share)	(2,438)					(2,438)
Other comprehensive income (loss)	280							280
Net (loss) income	(6,617)					(6,617)
Balance, end of period (in shares) at Mar. 31, 2021			81,246
Balance, end of period at Mar. 31, 2021	478,925		$ 812	140,558		340,223		(2,668)
Balance, beginning of period (in shares) at Dec. 31, 2020			80,890
Balance, beginning of period at Dec. 31, 2020	542,172	$ (52,205)	$ 809	204,432	$ (61,604)	339,879	$ 9,399	(2,948)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	1,862
Net (loss) income	30,674
Balance, end of period (in shares) at Jun. 30, 2021			81,456
Balance, end of period at Jun. 30, 2021	522,468		$ 815	147,670		375,069		(1,086)
Balance, beginning of period (in shares) at Mar. 31, 2021			81,246
Balance, beginning of period at Mar. 31, 2021	478,925		$ 812	140,558		340,223		(2,668)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)			(81)
Repurchase of common stock	(10,246)		$ (1)	(10,245)
Issuance of common stock for share-based compensation plans (in shares)			267
Issuance of common stock for stock compensation plans	(16,196)		$ 3	(16,199)
Issuance of common stock under the employee stock purchase plan (in shares)			24
Issuance of common stock under the employee stock purchase plan	2,859		$ 1	2,858
Stock-based compensation	30,698			30,698
Cash dividends declared ($0.03 per share)	(2,445)					(2,445)
Other comprehensive income (loss)	1,582							1,582
Net (loss) income	37,291					37,291
Balance, end of period (in shares) at Jun. 30, 2021			81,456
Balance, end of period at Jun. 30, 2021	$ 522,468		$ 815	147,670		375,069		(1,086)
Balance, beginning of period (in shares) at Dec. 31, 2021	81,712		81,712
Balance, beginning of period at Dec. 31, 2021	$ 416,088		$ 817	145,810		276,449		(6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)			(242)
Repurchase of common stock	(22,583)		$ (2)	(22,581)
Issuance of common stock for share-based compensation plans (in shares)			297
Issuance of common stock for stock compensation plans	(12,128)		$ 3	(12,131)
Issuance of common stock under the employee stock purchase plan (in shares)			35
Issuance of common stock under the employee stock purchase plan	2,446			2,446
Stock-based compensation	28,227			28,227
Cash dividends declared ($0.03 per share)	(2,455)					(2,455)
Other comprehensive income (loss)	(2,548)							(2,548)
Net (loss) income	(379)					(379)
Balance, end of period (in shares) at Mar. 31, 2022			81,802
Balance, end of period at Mar. 31, 2022	$ 406,668		$ 818	141,771		273,615		(9,536)
Balance, beginning of period (in shares) at Dec. 31, 2021	81,712		81,712
Balance, beginning of period at Dec. 31, 2021	$ 416,088		$ 817	145,810		276,449		(6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(15,163)
Net (loss) income	$ (286,675)
Balance, end of period (in shares) at Jun. 30, 2022	81,940		81,940
Balance, end of period at Jun. 30, 2022	$ 133,779		$ 819	170,251		(15,140)		(22,151)
Balance, beginning of period (in shares) at Mar. 31, 2022			81,802
Balance, beginning of period at Mar. 31, 2022	406,668		$ 818	141,771		273,615		(9,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)			(38)
Repurchase of common stock	(1,925)		$ 0	(1,925)
Issuance of common stock for share-based compensation plans (in shares)			117
Issuance of common stock for stock compensation plans	(3,251)		$ 1	(3,252)
Issuance of common stock under the employee stock purchase plan (in shares)			59
Issuance of common stock under the employee stock purchase plan	2,357			2,357
Stock-based compensation	31,300			31,300
Cash dividends declared ($0.03 per share)	(2,459)					(2,459)
Other comprehensive income (loss)	(12,615)							(12,615)
Net (loss) income	$ (286,296)					(286,296)
Balance, end of period (in shares) at Jun. 30, 2022	81,940		81,940
Balance, end of period at Jun. 30, 2022	$ 133,779		$ 819	$ 170,251		$ (15,140)		$ (22,151)